We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+4.53%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$13.4B
AUM Growth
+$1.17B
(+9.6%)
Cap. Flow
+$978M
Cap. Flow
% of AUM
7.33%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
925
New
124
Increased
306
Reduced
365
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$137M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$104M |
| 3 |
Carrier Global
CARR
|
+$104M |
| 4 |
UnitedHealth
UNH
|
+$99.3M |
| 5 |
NextEra Energy
NEE
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$94.1M |
| 2 |
Mastercard
MA
|
+$93.1M |
| 3 |
Visa
V
|
+$75.8M |
| 4 |
Cadence Design Systems
CDNS
|
+$70.9M |
| 5 |
3M
MMM
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.73% |
| 2 | Healthcare | 16.05% |
| 3 | Financials | 12.84% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
476
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $430K | ﹤0.01% |
3,300
-3,603
| -52% | -$432K |
|
477
ARK Innovation ETF
ARKK
$6.37B
| $423K | ﹤0.01% |
3,529
+244
| +7% | +$33K |
|
478
Dollar Tree
DLTR
$24.9B
| $421K | ﹤0.01% |
3,679
+1,689
| +85% | +$181K |
|
479
Sprouts Farmers Market
SFM
$7.96B
| $421K | ﹤0.01% |
15,815
-43,886
| -74% | -$998K |
|
480
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
| $415K | ﹤0.01% |
6,500
+2,505
| +63% | +$176K |
|
481
ARK Web x.0 ETF
ARKW
$1.77B
| $405K | ﹤0.01% |
2,750
+2,121
| +337% | +$342K |
|
482
iShares MSCI World ETF
URTH
$8.34B
| $402K | ﹤0.01% |
+3,391
| New | +$394K |
|
483
ProShares UltraPro Short S&P 500
SPXU
$384M
| $397K | ﹤0.01% |
838
-81
| -9% | -$42.9K |
|
484
Agnico Eagle Mines
AEM
$91.4B
| $389K | ﹤0.01% |
6,725
-1,033
| -13% | -$66.8K |
|
485
Tandem Diabetes Care
TNDM
$1.59B
| $388K | ﹤0.01% |
4,400
| – | – |
|
486
Quest Diagnostics
DGX
$26.2B
| $384K | ﹤0.01% |
2,991
+885
| +42% | +$109K |
|
487
iShares China Large-Cap ETF
FXI
$4.35B
| $382K | ﹤0.01% |
8,178
+80
| +1% | +$3.97K |
|
488
VF Corp
VFC
$5.86B
| $380K | ﹤0.01% |
4,751
-3,211
| -40% | -$261K |
|
489
iShares MSCI India ETF
INDA
$6.6B
| $379K | ﹤0.01% |
9,000
+8,801
| +4,423% | +$369K |
|
490
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
| $372K | ﹤0.01% |
3,053
+1,513
| +98% | +$179K |
|
491
Digital Realty Trust
DLR
$70.8B
| $369K | ﹤0.01% |
2,618
-299
| -10% | -$41.3K |
|
492
Expeditors International
EXPD
$23.3B
| $366K | ﹤0.01% |
3,401
+1,035
| +44% | +$99.6K |
|
493
iShares MSCI Germany ETF
EWG
$1.67B
| $358K | ﹤0.01% |
10,707
+320
| +3% | +$10.4K |
|
494
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
| $356K | ﹤0.01% |
2,626
+1,402
| +115% | +$203K |
|
495
Regeneron Pharmaceuticals
REGN
$83.2B
| $355K | ﹤0.01% |
750
-111
| -13% | -$54K |
|
496
Vontier
VNT
$4.63B
| $346K | ﹤0.01% |
11,430
+5,831
| +104% | +$190K |
|
497
iShares MSCI Japan Value ETF
EWJV
$743M
| $344K | ﹤0.01% |
12,287
+3,031
| +33% | +$83.4K |
|
498
iShares US Medical Devices ETF
IHI
$3.44B
| $337K | ﹤0.01% |
6,126
-11,418
| -65% | -$633K |
|
499
PACCAR
PCAR
$69.1B
| $328K | ﹤0.01% |
5,294
+513
| +11% | +$32.1K |
|
500
Xylem
XYL
$28.3B
| $326K | ﹤0.01% |
3,099
-10,851
| -78% | -$1.1M |
|
Similar funds
Bank Julius Baer & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Bank Julius Baer & Co held 925 positions worth $13.4B, up 9.6% from $12.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bank Julius Baer & Co deployed $978M of net new capital in Q1 2021, opening 124 new positions and adding to 306 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $94.1M trimmed.
- Bank Julius Baer & Co's largest Q1 2021 buy was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.
- Bank Julius Baer & Co added most to JPMorgan Chase in Q1 2021, an estimated $137M increase.
- Bank Julius Baer & Co's biggest Q1 2021 reduction was Salesforce, cutting an estimated $94.1M.
- Bank Julius Baer & Co fully exited Invesco Equal Weight 0-30 Year Treasury ETF in Q1 2021, selling an estimated $12.1M.
- Bank Julius Baer & Co's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
- Bank Julius Baer & Co opened 124 new positions and closed 113 in Q1 2021.
- Bank Julius Baer & Co's portfolio value rose 9.6% quarter-over-quarter to $13.4B.
Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.